Inhibitory Effect of Japanese Traditional Kampo Formula Frequently Prescribed in Gynecological Clinics on CYP3A4

被引:4
作者
Ni, Hao [1 ]
Matsumoto, Takashi [2 ]
Watanabe, Junko [2 ]
Makino, Toshiaki [1 ]
机构
[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan
[2] Tsumura & Co, Kampo Res & Dev Div, Tsumura Kampo Res Labs, 3586 Yoshiwara, Ami, Ibaraki 3001192, Japan
关键词
CYTOCHROME-P450; 3A4; DRUG INTERACTIONS; HERBAL MEDICINES; P-GLYCOPROTEIN; EXTRACT;
D O I
10.1155/2018/4259603
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Recently, the use of herbal medicines has become popular, and information on drug interactions between herbal medicines and chemical drugs is needed in clinics. In Japan, the number of patients taking Japanese traditional Kampo medicines has been increasing, and the proper drug information about herb-drug interaction is highly demanded. The most established herb-drug interaction is the case of grapefruit juice (GFJ) via the inhibition on CYP3A4 expressed in the small intestine. In the present study, we compared the inhibitory titer on CYP3A4 between the target Kampo products and GFJ used as positive control. We evaluated the inhibitory effects of GFJ and three extracts of Kampo formulas frequently used in gynecological clinics on CYP3A4 in vitro and calculated the related titer of one-time dosage of Kampo formulas to GFJ in order to predict its effect on clinics. Although the extracts of these three Kampo formulas and the most of crude drug components in the formulas exhibited the inhibitory effects on CYP3A4 in some levels, the possibilities of tokishakuyakusan and keishibukuryogan to cause drug interaction can be quite low; however, it is possible that the excessive dosage of kamishoyosan may cause drug interaction with the substrate of CYP3A4 in clinics.
引用
收藏
页数:7
相关论文
共 21 条
  • [1] [Anonymous], 2016, The Japanese Pharmacopoeia, V17th
  • [2] INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE
    BAILEY, DG
    SPENCE, JD
    MUNOZ, C
    ARNOLD, JMO
    [J]. LANCET, 1991, 337 (8736) : 268 - 269
  • [3] Evidence-based drug-herbal interactions
    Chavez, ML
    Jordan, MA
    Chavez, PI
    [J]. LIFE SCIENCES, 2006, 78 (18) : 2146 - 2157
  • [4] Herb-drug interactions: Review and assessment of report reliability
    Fugh-Berman, A
    Ernst, E
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (05) : 587 - 595
  • [5] The effect of grapefruit juice on drug disposition
    Hanley, Michael J.
    Cancalon, Paul
    Widmer, Wilbur W.
    Greenblatt, David J.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (03) : 267 - 286
  • [6] Effects of Kampo medicines on CYP and P-gp activity in vitro
    Ito, Kiyomi
    Satoh, Toshiyuki
    Watanabe, Yuka
    Ikarashi, Nobutomo
    Asano, Takayuki
    Morita, Toshimi
    Sugiyama, Kiyoshi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) : 893 - 896
  • [7] Effects of Furanocoumarins in Kampo Extract-Based Medicines on Rat Intestinal Absorption of CYP3A and P-glycoprotein Substrate Drugs In Vivo
    Iwanaga, Kazunori
    Arimune, Kaori
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2012, 35 (06) : 1055 - 1064
  • [8] Furanocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-Glycoprotein
    Iwanaga, Kazunori
    Hayashi, Manami
    Hamahata, Yukimi
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    [J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) : 1286 - 1294
  • [9] Japan Kampo Medicines Manufactures Association under the super vision of National Institute of Health Sciences the affiliated institutions of theMinistry of Health Labour and Welfare of Japan, 2013, HDB OTC MED PRODUCT
  • [10] Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents
    Li, Guannan
    Simmler, Charlotte
    Chen, Luying
    Nikolic, Dejan
    Chen, Shao-Nong
    Pauli, Guido F.
    van Breemen, Richard B.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : 182 - 190